Imunon, Inc.
IMNN· Nasdaq
Filed May 12, 2026 · 10-Q · 42 days after period end · 0001493152-26-022416
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$4.25M | -$4.10M | -$4.93M | -$5.59M |
| EPS Diluted | -$0.84 | -$3.15 | -$0.52 | -$0.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 12, 2026 · 42 d after period end